Design and Conduct Considerations for First‐in‐Human Trials
A milestone step in translational science to transform basic scientific discoveries into therapeutic applications is the advancement of a drug candidate from preclinical studies to initial human testing. First‐in‐human (FIH) trials serve as the link to advance new promising drug candidates and are c...
Saved in:
Main Authors: | Jie Shen (Author), Brandon Swift (Author), Richard Mamelok (Author), Samuel Pine (Author), John Sinclair (Author), Mayssa Attar (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and conduct considerations for studies in patients with hepatic impairment
by: Paulien Ravenstijn, et al.
Published: (2023) -
Design and conduct considerations for studies in patients with impaired renal function
by: Paulien Ravenstijn, et al.
Published: (2021) -
Key considerations for conducting Chinese medicine clinical trials in hospitals
by: Shergis Johannah L, et al.
Published: (2013) -
Recommendations in the design and conduction of randomised controlled trials in human and veterinary homeopathic medicine
by: Katharina Gaertner, et al.
Published: (2023) -
Considerations on Conducting Research on Wellness in the Context of the Learning Environment
by: Larry D Gruppen, et al.
Published: (2021)